What Karuna Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Torres Denice | Director | Mar 18 | Disposition to Issuer · D | −990 | $330.00 | −$327K | 0 |
| Wheadon David E. | Director | Mar 18 | Disposition to Issuer · D | −990 | $330.00 | −$327K | 0 |
| Meury William | President and CEO | Mar 18 | Disposition to Issuer · D | −19,037 | $330.00 | −$6.28M | 0 |
| Meury William | President and CEO | Mar 18 | Disposition to Issuer · D | −10,342 | $330.00 | −$3.41M | 19,037 |
| Paul Steven M | Director | Mar 18 | Disposition to Issuer · D | −35,877 | $330.00 | −$11.8M | 0 |
| Paul Steven M | Director | Mar 18 | Disposition to Issuer · D | −30,304 | $330.00 | −$10M | 0 |
| Paul Steven M | Director | Mar 18 | Disposition to Issuer · D | −33,882 | $330.00 | −$11.2M | 0 |
| Paul Steven M | Director | Mar 18 | Disposition to Issuer · D | −10,000 | $330.00 | −$3.3M | 0 |
| Paul Steven M | Director | Mar 18 | Disposition to Issuer · D | −30,304 | $330.00 | −$10M | 0 |
| Paul Steven M | Director | Mar 18 | Disposition to Issuer · D | −8,550 | $330.00 | −$2.82M | 0 |
| Paul Steven M | Director | Mar 18 | Disposition to Issuer · D | −2,046 | $330.00 | −$675K | 8,550 |
| Pande Atul | Director | Mar 18 | Disposition to Issuer · D | −990 | $330.00 | −$327K | 0 |
| Brannan Stephen K. | Chief Medical Officer | Mar 18 | Disposition to Issuer · D | −6,487 | $330.00 | −$2.14M | 0 |
| Brannan Stephen K. | Chief Medical Officer | Mar 18 | Disposition to Issuer · D | −36,117 | $330.00 | −$11.9M | 6,487 |
| Miller Andrew Craig | President of R&D | Mar 18 | Disposition to Issuer · D | −9,412 | $330.00 | −$3.11M | 0 |
| Miller Andrew Craig | President of R&D | Mar 18 | Disposition to Issuer · D | −13,977 | $330.00 | −$4.61M | 9,412 |
| Kane William P Jr | Chief Commercial Officer | Mar 18 | Disposition to Issuer · D | −8,828 | $330.00 | −$2.91M | 0 |
| Kane William P Jr | Chief Commercial Officer | Mar 18 | Disposition to Issuer · D | −5,000 | $330.00 | −$1.65M | 8,828 |
| Coughlin Christopher J | Director | Mar 18 | Disposition to Issuer · D | −990 | $330.00 | −$327K | 0 |
| Jonas Jeffrey M | Director | Mar 18 | Disposition to Issuer · D | −990 | $330.00 | −$327K | 0 |
Loading...